PGXL TECHNOLOGIES LLC

Medtech · Acquired

Non-invasive urine-based multiplexed immunoassay for screening obstructive sleep apnea in children

Grants
$2.3M
6 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
$606K
3 awards · Veterans Affairs, Health and Human S
#369 of 4531 in medtech
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal contractDepartment of Veterans Affairs · Small Purchase Data$8,700
Federal contractDepartment of Health and Human Services · Igf::ot::igf Detection, Isolation, And Analysis Of Single Ctcs$299,654
Federal contractDepartment of Health and Human Services · Igf::ot::igf R&d- Medical: Biomedical (basic Research)$298,132
Federal grantDepartment of Health and Human Services · Phase I · A Non-invasive Assay for Obstructive Sleep Apnea$224,628
Federal grantDepartment of Health and Human Services · Phase I · A Non invasive Assay for Obstructive Sleep Apnea$224,628
Federal grantDepartment of Health and Human Services · Phase I · A sleep biomarker test for management of ADHD$309,250
Federal grantDepartment of Health and Human Services · Phase I · Novel Urine Collection Kit for Obstructive Sleep Apnea$328,047
Federal grantDepartment of Health and Human Services · Phase II · UroMarker Test Panel for Obstructive Sleep Apnea$301,224
Federal grantDepartment of Health and Human Services · Phase II · UroMarker Test Panel for Obstructive Sleep Apnea$960,998
Federal grant · SBIR/STTRFederal contract · USAspending

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
366Beacon Biosignals$641K$133M
367Medigus$623K$8.6M
368Sentien Biotechnologies, Inc.$610K$1.0M
369PGXL TECHNOLOGIES LLC$606K—
370Ribomed Biotechnologies, Inc.$603K—
371SONATA SCIENTIFIC LLC$600K—
372BIG EYE DIAGNOSTICS INC$600K—

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.